Skip to content

Author

Ahmad Jamal

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Nov 2026

2-Chloro-3-Hydrazinylquinoxaline Mitigates Doxorubicin-Induced Hepatic Inflammation in Rats.

BACKGROUND In this research, 2-chloro-3-hydrazinylquinoxaline (CHQ) was evaluated for hepatoprotection and mechanism of action against the hepatotoxicity and liver inflammation in rats induced by the drug doxorubicin (DOX). METHODS Twenty-four male Wistar rats were split into four groups (n = 6 per group): normal con...

A. Azhari, N. Juma, N. Helmi et al. · 0 citations
Open access Nov 2026

Protective Role of 2,3-Dichloro-6-(Trifluoromethoxy)Quinoxaline against DOX-induced Liver Inflammation

Doxorubicin (DOX) is a powerful anthracycline anti-neoplastic agent, and its therapeutic application is frequently restricted because of its liver-damaging effects. In this study, we found that DOX induces acute liver toxicity in rats, and the mechanisms underlying these effects were investigated. This study...

M. Alkasih, N. Juma, H. Niyazi et al. · 0 citations
Review Open access Oct 2026

Cancer Stem Cells as Central Nodes in Therapeutic Strategies

Cancer stem cells (CSCs) are a small population of cancer cells that endow unique traits of self-renewal, differentiation, tumorigenicity, quiescence and therapeutic resistance, ultimately leading to cancer relapse and poor prognosis. Conventional chemo- and radiotherapies effectively destroy rapidly dividing cancer ce...

Saima Usman, W. Yeudall, Ahmad Jamal et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.